MarketPeel
Insider Trading Intelligence
Pricing
…
GP

Gregory S. Patrick

SUPN
SR. VP CHIEF FINANCIAL OFFICER · SUPERNUS PHARMACEUTICALS, INC. · CIK 0001219844
FILING MIX · LIFETIME28%/72%
BUYS
5
SELLS
13
TOTAL VALUE
$1.92M
COMPANIES
1
ACTIVE SINCE
Feb 2020
HOLDINGS NOW
44,463
AVG SELL PX
$22.96
TRADE KIND
SHOWING 18 / 18
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
5 backtested trades · 8 horizons
Forward-return performance of every backtestable P/S trade by Gregory S. Patrick, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d5+60.00%-2.75%+0.48%-3.22%-0.25%—
14d5+60.00%-6.06%+0.82%-6.88%-4.79%—
30d5+60.00%+0.77%+5.41%-4.64%-4.95%—
60d5+20.00%+5.28%+7.23%-1.96%+1.27%—
90d5+0.00%+19.07%+11.85%+7.22%+12.48%—
180d5+40.00%+18.65%+20.16%-1.52%-2.23%—
1y5+0.00%+37.89%+37.64%+0.25%+2.12%—
2y5+0.00%+33.51%+20.09%+13.42%+22.35%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
SUPN · 44,463 shares · as of Nov 9, 2020
015,26430,52945,79361,057SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2020
FLOW · 5 buys / 13 sellsCOVERAGE · 4 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILED
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
Sr. VP Chief Financial Officer
5,000——10,000Nov 9, 2020Nov 10, 2020 ↗
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
Sr. VP Chief Financial Officer
5,000$12.98$64.9K49,463Nov 9, 2020Nov 10, 2020 ↗
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
Sr. VP Chief Financial Officer
5,000$25.00$125.0K44,463Nov 9, 2020Nov 10, 2020 ↗
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
Sr. VP, CFO
5,000$12.98$64.9K49,463Nov 5, 2020Nov 6, 2020 ↗
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
Sr. VP, CFO
5,000$23.00$115.0K44,463Nov 5, 2020Nov 6, 2020 ↗
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
Sr. VP, CFO
5,000——15,000Nov 5, 2020Nov 6, 2020 ↗
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
Sr. VP, CFO
15,000——20,000Oct 15, 2020Oct 15, 2020 ↗
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
Sr. VP, CFO
15,000$12.98$194.7K59,463Oct 15, 2020Oct 15, 2020 ↗
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
Sr. VP, CFO
15,000$20.03$300.5K44,463Oct 15, 2020Oct 15, 2020 ↗
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALEGRANT
Gift
1,120——44,463Aug 27, 2020Aug 28, 2020 ↗
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALEGRANT
Gift
1,000——45,583Aug 25, 2020Aug 28, 2020 ↗
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
Sr.VP, Chief Financial Officer
15,000——35,000May 20, 2020May 20, 2020 ↗
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
Sr.VP, Chief Financial Officer
15,000$25.03$375.4K46,057May 20, 2020May 20, 2020 ↗
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
Sr.VP, Chief Financial Officer
15,000$12.98$194.7K61,057May 20, 2020May 20, 2020 ↗
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
Sr VP, Chief Financial Officer
15,000——0May 8, 2020May 8, 2020 ↗
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
Sr VP, Chief Financial Officer
15,000$23.14$347.0K46,057May 8, 2020May 8, 2020 ↗
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
Sr VP, Chief Financial Officer
15,000$9.13$136.9K61,057May 8, 2020May 8, 2020 ↗
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALEGRANT
Stock grant
50,000——50,000Feb 21, 2020Feb 25, 2020 ↗
Other insiders · SUPN
Loading peer insiders…
About this filer
CIK 0001219844
ROLE
Sr. VP Chief Financial Officer
PRIMARY
SUPN
COMPANIES
1
ACTIVE SINCE
Feb 2020
MARKETPEEL · /INSIDER/0001219844DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback